In 2011, the United States Preventive Services Task Force (USPSTF) issued a grade of “D” to the prostate specific antigen (PSA) test. A “D” grade generally means that the test does more harm than good. But is that really the case? Prior to the USPSTF announcement, the PSA test was
“There is now sufficient data to support the use of prostate MRI in all men before their initial prostate biopsy when the MRI is of sufficient quality.” – Marc A. Bjurlin, DO, MSc., AUA Policy Statement Co-Author Multiparametric prostate MRI (mpMRI) recently received a huge boost when the American Urological
HALO Diagnostics is proud to report the first 10 years of results for a clinical trial on the efficacy of MRI-guided laser focal therapy. Over 170 men, 45-years or older diagnosed with low-to-intermediate risk or recurrent prostate cancer, volunteered to participate in the study. The results are remarkable and offer
Early detection saves lives. HALO is setting the new standard for prostate care.
